| Financial Year |
March 31 2023 |
| Monetary Funds |
3,205,726,731.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,650,159.87 |
| Accounts Receivable |
2,662,169,983.71 |
| Advances to Suppliers |
40,471,110.11 |
| Other Receivables |
127,953,559.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,220,458,245.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
22,942,945.71 |
| Other Current Assets |
131,327,723.34 |
| Total Current Assets |
17,642,662,022.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
619,925,372.82 |
| Long-term Equity Investment |
3,291,610,218.96 |
| Investment Properties |
4,729,820,909.64 |
| Fixed Assetes |
1,407,245,474.64 |
| Under-construction Projects |
922,698,371.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
188,753,351.01 |
| R&D expenses |
-- |
| Goodwill |
134,698,289.11 |
| Long-Term Deferred and Prepaid Expenses |
12,842,175.45 |
| Deferred Income Tax Assets |
166,728,477.98 |
| Other Non-Current Assets |
202,861,072.38 |
| Sub-Total of Non-Current Assets |
15,173,527,536.35 |
| Total Assets |
32,816,189,559.00 |
| Short-Term Loans |
1,632,994,951.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,406,382,448.44 |
| Accounts Received In Advance |
104,992,962.33 |
| Employee Compensation Payable |
175,320,328.23 |
| Taxes Payable |
291,735,703.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,031,594,251.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
378,452,600.48 |
| Other Current Liabilities |
154,304,636.97 |
| Sub-Total of Current Liabilities |
7,770,626,187.30 |
| Long-term Loans |
5,170,116,371.31 |
| Bonds Payable |
998,483,780.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,426,590.49 |
| Other Non-Current Liabilities |
93,570,537.38 |
| Sub-Total of Non-Current Liabilities |
6,517,563,759.70 |
| Total Liabilities |
14,288,189,947.00 |
| Paid-In Capital(Or Share Stock) |
1,498,890,000.00 |
| Capital Surplus |
1,233,993,266.96 |
| Surplus Reserve |
749,445,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,267,541,253.86 |
| Minority Stockholder's Interest |
4,776,299,070.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,751,700,541.44 |
| Owner's Equity（Stockholder's Equity） |
18,527,999,612.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,816,189,559.00 |
